Propanc Biopharma Highlights Therapeutic Potential of PRP
MELBOURNE, AUSTRALIA--(Marketwired - September 27, 2017) - Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or "the Company"), a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments …